ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Community Clinical Oncology Program Renewed, NCI Hopes To Restore Cuts In ’08.

March 30, 2007

In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director

October 1, 1993

AACR honors Five With Awards Next Month

April 2, 1993

IOM Calls For Rapid Reform Of Health Case System.

March 9, 2001

Study Finds Relationship Between Meat Intake, Cancer

August 27, 2010

Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.

June 2, 2000